AMR Stakeholder Network
Call for good practices to tackle antimicrobial resistance
Deadline | 15 March 2021 17:00 CET
Do you have a good practice to share in the fight against AMR?
The AMR Stakeholder Network is collecting examples of good practices in the fight against superbugs across Europe.
Does you local hospital have good hygiene practices?
Did you take part in an awareness-raising campaign to change public opinion about antibiotic use you can share?
Do you know of a good practice to reduce the use of antibiotics in animal farming you can share?
Have you noticed a good campaign to prevent over-prescribing or over-use of antibiotics?
Helping to find the hidden invention or re-discovering existing good practices so they can be shared more widely can help tackle antibiotic resistance in Europe
The Network will collect, and select simple, proven practices and bring them to the attention of the European Union, national governments and other health policymakers. We will organise a European wide dissemination campaign to extend their use across Europe to help tackle antimicrobial resistance and help strengthen Europe’s AMR “safety net” in the aftermath of the Coronavirus pandemic – more important than ever, given the current lack of a coordinated, harmonised pandemic surveillance and response mechanism to tackle serious cross-border threats to healthcare.
Criteria for submitting your AMR good practice
1.The good practice should tackle one or more of the areas of the Stakeholder Network’s Roadmap for action on Antimicrobial Resistance
Set targets and performance indicators
Help countries mobilise resources for better implementation
Close the existing collaboration gap between civil society and EU policy-makers
Put prevention at the heart of AMR policy-making
Tackle the environmental dimension of AMR in the framework of the European Green Deal
2. The good practice can be tackle AMR in human, animal and environmental health. Let us know if it tackles more than one of these areas.
AMR can only be addressed through a multi-disciplinary approach, integrating human and animal health as well as environmental perspectives. EU and national decision-makers must therefore adopt a true ‘One Health’ approach in their actions to tackle AMR.
Submissions for inclusion into an “AMR good practice” publication will be evaluated according to criteria such as:
how how far they might achieve one or more of the aims of the Roadmap
how many people have been reached by the best practice
how it has added value to existing initiatives or makes a unique contribution to tackling AMR
how it supports tackling AMR amongst a particular vulnerable group
Submissions will be evaluated by a Selection Committee made up of members of the AMR Stakeholder Network with expertise in the different One Health areas of AMR.
How to share your AMR good practice
Submissions can be made by completing the form here.
Any attachments in support of your submission can be sent to Zoltàn Massay-Kosubek at email@example.com. Please contact him if you have any questions about the process.
Taking account the many pressures on organisations because of the ongoing pandemic, the deadline has been extended to 15 March 2021 | 17:00 CET
The facts about AMR
Antimicrobial resistance (AMR) is a serious global health threat. Each year, 750,000 people die globally as a consequence of drug-resistant bacteria – with 33,000 annual deaths in Europe. The World Bank estimates that AMR could push 28 million people into extreme poverty by 2050 with an annual economic impact of more than USD $1 trillion after 2030.
Superbugs cost the life of nearly 90 people every day in the EU and the EEA. A serious threat to patient safety, AMR crosses national borders and endangers many healthcare interventions, including life-saving surgical procedures and cancer treatments. The development and spread of multi-drug resistance has far-reaching and potentially life-threatening consequences for humans, animals and the environment, and jeopardises the achievement of the Sustainable Development Goals (SDGs).
About the AMR Stakeholder Network: Transforming commitments to action
The AMR Stakeholder Network is the largest civil society-led AMR coalition active at the European and national level, with members in over 13 European countries.
The Network activities are concentrated around its 2019 Roadmap for Action on Antimicrobial Resistance, which outlines five key strategies and targets to tackle AMR and supports the implementation of the One Health Action Plan:
1. Set targets and performance indicators;
2 Help countries mobilise resources for better implementation of national AMR policies;
3. Close the existing collaboration gap between civil society and EU policy-makers;
4 .Put prevention at the heart of AMR policy-making;
5. Tackle the environmental dimension of AMR in the framework of the European Green Deal.
As one way of turning the commitments of the Roadmap into concrete action, the Stakeholder Network is compiling a collection of case studies to highlight good practices in One Health areas.